Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence

Bone Marrow Transplantation volume 37, pages 1109–1117 (2006)Cite this article

Abstract

Endocrine dysfunction and parameters of metabolic syndrome were assessed in 91 patients aged 4.3–32.5 years who underwent allogeneic or autologous BMT in childhood. Final short stature, found in five of the 35 patients who attained final height, was associated with the underlying disease (specifically, Fanconi anemia) (P=0.0013), previous cranial irradiation (P=0.0007), type of conditioning irradiation (P<0.05) and allogeneic BMT (P=0.05). Growth hormone deficiency (n=10) was associated with previous cranial irradiation (P<0.005) and conditioning total body irradiation (P<0.001). Twelve patients had primary hypothyroidism, one had hyperthyroidism and one papillary thyroid carcinoma. Hypothyroidism was associated with neck/mediastinal (P<0.005) and conditioning irradiation (P<0.05). Primary gonadal failure was found in 24 of the mature patients (62.5% females). Hypogonadism was associated with the underlying disease (especially hematological malignancies) (P<0.05), pretransplant treatment (P<0.05), irradiation conditioning (P<0.001), older age (P<0.005) and advanced pubertal stage at BMT (P<0.05). Obesity (body mass index >2 s.d.) was found in 4.4% and type II diabetes and impaired glucose tolerance in 3.3% each. Dyslipidemia was found in 27.9% of the 43 patients tested. These findings emphasize the need for long-term follow-up of endocrine and metabolic parameters in young patients after BMT in order to offer proper treatment and improve quality of life.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Shalet SM . Endocrine consequences of treatment of malignant disease. Arch Dis Child 1989; 64: 1635–1641.

    Article  CAS  Google Scholar 

  2. Kolb HJ, Bender-Gotze C . Late complications after allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant 1990; 6: 61–72.

    CAS  PubMed  Google Scholar 

  3. Kashyap A, Kadeel F, Yamauchi D, Palmer JM, Niland JC, Molina A et al. Effects of allogeneic bone marrow transplantation on recipient bone mineral density: a prospective study. Biol Blood Marrow Transplant 2000; 6: 344–351.

    Article  CAS  Google Scholar 

  4. Brauner R, Fontoura M, Zucker JM, Devergie A, Souberbielle JC, Prevot-Saucet C et al. Growth and growth hormone secretion after bone marrow transplantation. Arch Dis Child 1993; 68: 458–463.

    Article  CAS  Google Scholar 

  5. Legault L, Bonny Y . Endocrine complications of bone marrow transplantation in children. Pediatr Transplant 1999; 3: 60–66.

    Article  CAS  Google Scholar 

  6. Toubert ME, Socie G, Gluckman E, Aractingi S, Esperou H, Devergie A et al. Short- and long term follow-up of thyroid dysfunction after allogeneic bone marrow transplantation without the use of preparative total body irradiation. Br J Haematol 1997; 98: 453–457.

    Article  CAS  Google Scholar 

  7. Shalet SM, Didi M, Oglivy-Stuart AL, Schulga J, Donaldson MD . Growth and endocrine function after bone marrow transplantation (Review). Clin Endocrinol 1995; 42: 333–339.

    Article  CAS  Google Scholar 

  8. Taskinen M, Saarinen-Pinkala UM, Hovi L, Lipsanen-Nyman M . Impaired glucose tolerance and dyslipidemia as late effects after bone-marrow transplantation in childhood. Lancet 2000; 16: 993–997.

    Article  Google Scholar 

  9. Marshall WA, Tanner JM . Variation in the pattern of pubertal changes in girls. Arch Dis Child 1969; 49: 291–303.

    Article  Google Scholar 

  10. Marshall WA, Tanner JM . Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970; 45: 13–23.

    Article  CAS  Google Scholar 

  11. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM . CDC Growth Charts: United States Advance Data From Vital and Health Statistics, No. 314. National Center for Health Statistics: Hyattsville, MD, 2000.

    Google Scholar 

  12. Rosenfield R . Puberty in the female and its disorders. In: Sperling MA (ed). Pediatric Endocrinology, 2nd edn. Elsevier Science: Pennsylvania, 2002, p 494.

    Google Scholar 

  13. Styne DM . The testes: disorders of sexual differentiation and puberty in the male. In: Sperling MA (ed). Pediatric Endocrinology, 2nd edn. Elsevier Science: Pennsylvania, 2002, p 599.

    Google Scholar 

  14. Dixon WJ . BMDP Statistical Software. University of California Press: Los Angeles, 1993.

    Google Scholar 

  15. Bakker B, Oostdijk W, Bresters D, Walenkamp MJ, Vossen JM, Wit JM . Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood. Bone Marrow Transplant 2004; 33: 1049–1056.

    Article  CAS  Google Scholar 

  16. Cohen A, Rovelli A, Van-Lint MT, Uderzo C, Morchio A, Pezzini C et al. Final height of patients who underwent bone marrow transplantation during childhood. Arch Dis Child 1996; 74: 437–440.

    Article  CAS  Google Scholar 

  17. Frisk P, Arvidson J, Gustafsson J, Lonnerholm G . Pubertal development and final height after autologous bone marrow transplantation for acute lymphoblastic leukemia. Bone Marrow Transplant 2004; 33: 205–209.

    Article  CAS  Google Scholar 

  18. Giorgiani G, Bozzola M, Locatelli F, Picco P, Zecca M, Cisternino M et al. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 1995; 86: 825–831.

    CAS  PubMed  Google Scholar 

  19. Sanders JE, Pritchard S, Mahoney P, Amos D, Buckner CD, Witherspoon RP et al. Growth and development following marrow transplantation for leukemia. Blood 1986; 68: 1129–1135.

    CAS  PubMed  Google Scholar 

  20. Shankar SM, Bunin NJ, Moshang T . Growth in children undergoing bone marrow transplantation after busulphan and cylophosphamide conditioning. J Pediatr Hematol Oncol 1996; 18: 362–366.

    Article  CAS  Google Scholar 

  21. Afify Z, Shaw PJ, Clavano-Harding A, Cowell CT . Growth and endocrine function in children with acute myeloid leukemia after bone marrow transplantation using busulphan/cylophosphamide. Bone Marrow Transplant 2000; 25: 1087–1092.

    Article  CAS  Google Scholar 

  22. Thompson RG, Rodriguez A, Kowarski A, Blizzard RM . Growth hormone: metabolic clearance rates, integrated concentrations, and production rates in normal adults and effect of prednisone. J Clin Invest 1972; 51: 3193–3199.

    Article  CAS  Google Scholar 

  23. Brauner R, Rappaport R, Prevot C, Czernichow P, Zucker JM, Bataini P et al. A prospective study of the development of growth hormone deficiency in children given cranial irradiation, and its relation to statural growth. J Clin Endocrinol Metab 1989; 68: 346–351.

    Article  CAS  Google Scholar 

  24. Ogilvy-Stuart AL, Clark DJ, Wallace WH, Wallace WH, Gibson BE, Stevens RF et al. Endocrine deficit after fractionated total body irradiation. Arch Dis Child 1992; 67: 1107–1110.

    Article  CAS  Google Scholar 

  25. Brauner R, Adan L, Souberbielle JC, Esperou H, Michon J, Devergie A et al. Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. J Pediatr 1997; 130: 785–792.

    Article  CAS  Google Scholar 

  26. Katsanis E, Shapiro RS, Robison LL, Haake RJ, Kim T, Pescovitz OH et al. Thyroid dysfunction following bone marrow transplantation: long-term follow-up of 80 pediatric patients. Bone Marrow Transplant 1990; 5: 335–340.

    CAS  PubMed  Google Scholar 

  27. Borgstrom B, Bolme P . Thyroid function in children after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 13: 59–64.

    CAS  PubMed  Google Scholar 

  28. Ishiguro H, Yasuda Y, Tomita Y, Shinagawa T, Shimizu T, Morimoto T et al. Long-term follow-up of thyroid function in patients who received bone marrow transplantation during childhood and adolescence. J Clin Endocrinol Metab 2004; 89: 5981–5986.

    Article  CAS  Google Scholar 

  29. Bouland F, Bromley M, Black P, Heller G, Sarafoglou K, Gillio A et al. Thyroid dysfunction following bone marrow transplantation using hyperfractionated radiation. Bone Marrow Transplant 1995; 15: 71–76.

    Google Scholar 

  30. Au WY, Lie AK, Kung AW, Liang R, Hawkins BR, Kwong YL . Autoimmune thyroid dysfunction after hematopoietic stem cell transplantation. Bone Marrow Transplant 2005; 35: 383–388.

    Article  CAS  Google Scholar 

  31. Sklar C, Whitton J, Mertens A, Stovall M, Green D, Marina N et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivors Study. J Clin Endocrinol Metab 2000; 85: 3227–3232.

    CAS  PubMed  Google Scholar 

  32. Socie G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH, Travis LB et al. New malignant diseases after allogeneic bone marrow transplantation for childhood acute leukemia. J Clin Oncol 2000; 18: 348–357.

    Article  CAS  Google Scholar 

  33. Sklar CA, Kim TH, Ramsay NK . Testicular function following bone marrow transplantation performed during or after puberty. Cancer 1984; 53: 1498–1501.

    Article  CAS  Google Scholar 

  34. Sarafoglou K, Boulad F, Gillio A, Sklar C . Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr 1997; 130: 210–216.

    Article  CAS  Google Scholar 

  35. Sanders JE . The impact of marrow transplant preparative regimens on subsequent growth and development. Semin Hematol 1991; 28: 244–249.

    CAS  PubMed  Google Scholar 

  36. Teinturier C, Hartmann O, Valteau-Couanet D, Benhamou E, Bougneres PF . Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant 1998; 22: 989–994.

    Article  CAS  Google Scholar 

  37. Lorini R, Cortona L, Scaramuzza A, De Stefano P, Locatelli F, Bonetti F et al. Hyperinsulinemia in children and adolescents after bone marrow transplantation. Bone Marrow Transplant 1995; 15: 873–877.

    CAS  PubMed  Google Scholar 

  38. Yang JY, Cui XL, He XJ . Non-ketotic hyperosmolar coma complicating steroid treatment in childhood nephrosis. Pediatr Nephrol 1995; 9: 621–626.

    Article  CAS  Google Scholar 

  39. Raul Ariza AC, Barile-Fabris LA, Frati-Munari AC, Baltazar- Montufan P . Risk factors for steroid diabetes in rheumatic patients. Arch Med Res 1998; 29: 259–262.

    Google Scholar 

  40. Zein CO, Levy C, Basu A, Zein NN . Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study. Am J Gastroenterol 2005; 100: 48–55.

    Article  Google Scholar 

  41. Kawaguchi T, Nagao Y, Tanaka K, Ide T, Harada M, Kumashiro R et al. Causal relationship between hepatitis C virus core and the development of type 2 diabetes mellitus in a hepatitis C virus hyperendemic area: a pilot study. Int J Mol Med 2005; 16: 109–114.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Pearl Lilos for the statistical analysis and Gloria Ginzach for the editorial assistance.

Author information

Authors and Affiliations

  1. Institute for Endocrinology and Diabetes, Schneider Children's Medical Center of Israel, Petach Tikva, Israel

    S Shalitin, M Phillip & D Carmi

  2. Department of Hematology and Oncology, Bone Marrow Transplantation Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel

    J Stein, Y Goshen & I Yaniv

  3. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    S Shalitin, M Phillip, J Stein, Y Goshen, D Carmi & I Yaniv

Authors
  1. S Shalitin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Phillip
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y Goshen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D Carmi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. I Yaniv
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Shalitin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shalitin, S., Phillip, M., Stein, J. et al. Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence. Bone Marrow Transplant 37, 1109–1117 (2006). https://doi.org/10.1038/sj.bmt.1705374

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705374

Keywords

This article is cited by

Search

Advanced search

Quick links